BN is a 74-year-old African American male who is seeing his PCP because he noticed when he woke up that his “heart
BN is a 74-year-old African American male who is seeing his PCP because he noticed when he woke up that his “heart
CASE SCENARIO
BN is a 74-year-old African American male who is seeing his PCP because he noticed when he woke up that his “heart was not beating right; it feels like it is going to slow.” He denies chest pain, SOB, N/V. He notes feeling dizzy earlier in the day. 6 weeks earlier his PCP started him on Diltiazem CD to further lower his BP to goal. His Metoprolol was lowered at that time as well from 75 mg to 50 mg BID. His PCP recommends he be admitted to the hospital.
Upon presentation to the hospital:
PMH:
- HTN x 7 years
- Type II DM
- CAD s/p angioplasty 2 years ago
- MI 3 years ago
- EF = 60%
- PVD s/p left femoral to posterior bypass
- Hx of A Fib x 4 years
Medications:
- Digoxin 0.25 mg QD KCl 40 mEq QD Vitamin C 500 mg QD
- Diltiazem CD 180 mg QD ASA EC 325 mg QD Vitamin E 400 IU QD
- Metoprolol 5- mg BID Warfarin 5 mg QD Ibuprofen 200 mg 2 tabs prn headache
- Lisinopril 20 mg QD Famotidine 20 mg QHS Multivitamin QD
- Imdur 30 mg QD Lantus 26u QHS Ca++/Vit D 500mg/200 IU BID
- HCTZ 12.5 mg QD Humalog 8u with meals
PE:
- BP 110/50 Pulse 38 bpm Resp 14/min
- Rest of physical exam unremarkable
Labs:
- K+ 6.9 WBC 5,800/mm3
- Na+ 135 Hct 35%
- Cr 1.9 Dig 2.78
- BUN 35 INR 2.3
- Gluc 102
Heart disease remains the No. 1 killer in America; nearly half of all Americans have high blood pressure, high cholesterol, or smoke—some of the leading risk factors for heart disease…
—Murphy et al., 2018
Despite the high mortality rates associated with cardiovascular disorders, improved treatment options do exist that can help address those risk factors that afflict the majority of the population today.
As an advanced practice nurse, it is your responsibility to recommend appropriate treatment options for patients with cardiovascular disorders. To ensure the safety and effectiveness of drug therapy, advanced practice nurses must consider aspects that might influence pharmacokinetic and pharmacodynamic processes such as medical history, other drugs currently prescribed, and individual patient factors.
To Prepare
- Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.
- Review the case study assigned by your Instructor for this Assignment.
- Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
- Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
- Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
- Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
BY DAY 7 OF WEEK 2
Write a 2- to 3-page paper that addresses the following:
- Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
- Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
- Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.
Requirements: 2 PAGES | .doc file
Masters Nursing
Answer preview for the paper on ‘BN is a 74-year-old African American male who is seeing his PCP because he noticed when he woke up that his “heart’
APA 839 words
Click the purchase button below to download full answer…….